top of page

In-depth analysis of the potential upcoming sickle cell gene therapy launches with ICER's president

Steve Pearson walks us through what the potential demand and patient accessibility dynamics of these key gene therapy launches might look like.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page